USE OF HUMAN URINARY KALLIDINOGENASE FOR MANUFACTURING A MEDICAMENT FOR THE TREATMENT AND/OR PREVENTION OF HYPERTENSION COMPLICATED BY CEREBRAL INFARCTION

摘要

A use of human urinary kallidinogenase for manufacturing a medicament for the treatment and/or prevention of hypertension complicated by cerebral infarction is provided. A pharmaceutical composition comprising human urinary kallidinogenase and pharmaceutically acceptable adjuvants is also provided. Human urinary kallidinogenase is efficacious against hypertension complicated by cerebral infarction. The present medicament is a pharmaceutical composition containing an appropriate proportion of human urinary kallidinogenase and pharmaceutically acceptable adjuvants, wherein the dosage form includes freeze-dried powder or injection solution.